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Honokiol blocks store operated calcium entry in
CHO cells expressing the M3 muscarinic receptor:
honokiol and muscarinic signaling
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Abstract
Background: Honokiol, a cell-permeable phenolic compound derived from the bark of magnolia trees and present
in Asian herbal teas, has a unique array of pharmacological actions, including the inhibition of multiple autonomic
responses. We determined the effects of honokiol on calcium signaling underlying transmission mediated by
human M3 muscarinic receptors expressed in Chinese hamster ovary (CHO) cells. Receptor binding was determined
in radiolabelled ligand binding assays; changes in intracellular calcium concentrations were determined using a
fura-2 ratiometric imaging protocol; cytotoxicity was determined using a dye reduction assay.
Results: Honokiol had a potent (EC50 ≈ 5 μmol/l) inhibitory effect on store operated calcium entry (SOCE) that was
induced by activation of the M3 receptors. This effect was specific, rapid and partially reversible, and was seen at
concentrations not associated with cytotoxicity, inhibition of IP3 receptor-mediated calcium release, depletion of ER
calcium stores, or disruption of M3 receptor binding.
Conclusions: It is likely that an inhibition of SOCE contributes to honokiol disruption of parasympathetic motor
functions, as well as many of its beneficial pharmacological properties.
Keywords: Honokiol, Calcium signaling, Store operated calcium entry (SOCE), Inositol trisphosphate (IP3), Muscarinic
acetylcholine receptor, Phospholipase Cβ
Background
Honokiol is a small, cell-permeable phenolic compound
derived from the bark of magnolia trees that is present in
Asian herbal teas. Honokiol has a unique array of anti-
angiogenic, antitumor and anti-inflammatory actions [1].
In the central and peripheral nervous systems, honokiol
has a neuroprotective effect, as well as effects on certain
signal transduction pathways. Honokiol is an effective
scavenger of reactive oxygen species [2], which may be
an important factor in its anti-inflammatory and neu-
roprotective actions [3-5]. Honokiol also has pronounced
anti-nociceptive effects, notably the nociception asso-
ciated with glutamate receptor activation [6,7]. Honokiol
inhibits muscarinic receptor- and depolarization-mediated
contraction of isolated porcine trachea, guinea pig ileum
and rat uterus, apparently by blocking the influx of ex-
tracellular calcium [8-10]. Thus, common aspects of
honokiol action in excitable tissues are an antioxidative
action and depression of glutamate-receptor and calcium
mediated signaling. It is possible that these are interrelated
factors.
The present research was undertaken to determine the
effects of honokiol on calcium signaling underlying trans-
mission mediated by muscarinic receptors expressed in
Chinese hamster ovary (CHO) cells, particularly receptor-
mediated release from the endoplasmic reticulum through
activated IP3 receptors and the subsequent store-operated
calcium entry (SOCE) that is induced by depletion of
calcium from the endoplasmic reticulum [11]. We report
that honokiol is a potent inhibitor of SOCE, with lesser
effects on resting calcium concentrations and calcium
release from the endoplasmic reticulum.
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enyl-phenol; Figure 1B) was synthesized and kindly pro-
vided by Dr. Chinpiao Chen, Department of Chemistry,
National Dong Hwa University, Hualien, Taiwan.
Cell culture and cytotoxicity measurements
CHO cells stably transfected with a clone of the human M3
muscarinic acetylcholine receptor (cDNA Resource Center,
www.cdna.org) were cultured in DME/F12 media con-
taining 10% FBS and penicillin/streptomycin (100 IU/
100 μg/ml) at 37° in a 5% CO2 humidified atmosphere.
Cell viability was determined using an MTS reduction assay
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium, inner salt; Promega,
Madison). Cells (≈ 7,000) were seeded into each well of a
96-well plate and incubated for 16 h. The cells were
exposed to honokiol for 24 h before cell viability was
determined.
Muscarinic receptor binding
[3H]N-methylscopolamine ([3H]MS; PerkinElmer), a
non-selective muscarinic antagonist, was used to label
muscarinic receptors from rat brain. Membranes from
the neocortex were homogenized in 50 mmol/l Tris–
HCl (pH 7.4), and an aliquot (15-30 μg protein) was
incubated in the presence of [3H]MS and 50 mmol/l
Tris–HCl (pH 7.4) for 60 minutes at room temperature
in a final volume of 1 ml. Binding was determined by
filtration of the suspension through glass fiber filters
(1 μm pore size), followed by measurement of the
radioactivity trapped on the filters by liquid scintillation
counting. Non-specific binding was determined in the
presence of 10 μmol/l atropine.
[3H]MS binding parameters (receptor concentration
[Bmax] and dissociation constant [KD]) were determined
by nonlinear regression (DeltaGraph) using a model for
a single population of independent binding sites. Agonist
binding was determined in competition studies using
carbamylcholine and 0.2 nmol/l [3H]MS.
Measurement of intracellular calcium
Cytosolic calcium concentration ([Ca2+]i) was measured in
a ratiometric assay using the calcium-sensitive fluorescent
dye, fura-2 (Molecular Probes). Cells (≈120,000) were seed-
ed onto 29 mm glass bottom dishes and incubated for 16 h.
The cells were then incubated with fura-2 AM for 60 min
at room temperature in a basal salt solution (BSS) com-
prised of 130 mmol/l NaCl, 5.4 mmol/l KCl, 5.5 mmol/l
glucose, 2 mmol/l CaCl2, 1 mmol/l MgCl2, and 20 mmol/l
HEPES, at pH 7.4. The cells were then washed twice with
BSS, and the incubation continued for an additional 30 min
before measuring calcium levels. Honokiol was present
during the last 10 min of the final incubation period.
[Ca2+]i. was determined at room temperature using an
InCyt Basic IM™ Fluorescence Imaging System (Intra-
cellular Imaging, Inc., Cincinnati, OH). The imaging
system was calibrated for calcium concentration using
standard calcium solutions of known concentration
(Invitrogen #C3722), according to manufacturer proto-
col. The ratio of fluorescence intensities measured at
512 nm after excitation at 340 and 380 nm is a reliable
indicator of [Ca2+]i..
Figure 1 Influence of honokiol on cellular responses to activation of M3 muscarinic receptors. CHO cells expressing the human M3
receptor were loaded with fura-2 to detect changes in cytosolic calcium concentration. The cells were untreated (A) or treated with the indicated
concentrations of honokiol for 10 min immediately prior to measuring calcium content (B). A: Control calcium responses to M3 receptor
activation. Carbamylcholine (10 μmol/l) was added at the time indicated by the first arrow. This lead to a rapid and sustained increase in cytosolic
calcium from 30 to 600-900 nmol/l. Addition of 5 mM EDTA to the medium (second arrow) decreased cytosolic calcium concentration. This is
consistent with the interpretation that the sustained increase in calcium concentration following receptor activation is dependent on the influx of
extracellular calcium through SOCE channels [12]. Each line represents the response of a single cell from typical experiment repeated over 100
times. B: Honokiol (inset) selectively depresses sustained calcium entry. The initial calcium response to receptor activation (arrow) was largely
unaffected by honokiol at concentrations up to 20 μmol/l, but 10 μmol/l honokiol blocked the sustained entry, suggesting a selective blockade of
SOCE. At higher concentrations both the initial and sustained responses were depressed. Each line represents the average response of 18-23 cells
from a typical experiment; 4 experiments yielded essentially similar results.
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Signals from 17-25 cells were measured in each plate.
Cells in which the resting [Ca2+]i. was not maintained at
a constant level (typically 1-2 cells/plate) were excluded
from the analysis, as were cells that completely failed to
respond to a muscarinic agonist (typically < 1 cell/plate).
To measure responses in the absence of extracellular
calcium, the cells were switched to calcium-free BSS
3 min before imaging.
Statistical analysis
Parameters (calcium concentrations, dissociation constants,
receptor concentrations, IC50’s) were compared as the
means from 3-6 independent experiments (with 3 replicates
in each binding measurement protocol and 17-23 replicates
in each calcium measurement protocol) using Student’s
t-test. Values from experiments with multiple indepen-
dent variables were compared by ANOVA and Tukey’s
test using GraphPad Prism software. Significant dif-
ferences were indicated by P values of < 0.05.
Results
Honokiol inhibition of muscarinic signaling
The resting cytosolic calcium concentration ([Ca2+]i) of
CHO-M3 cells in BSS in this series of experiments was
32.7 ± 9.8 nmol/l (mean ± S.D.; N = 5). Stimulation with
the muscarinic agonist carbamylcholine (10 μmol/l) led
to a rapid and sustained increase in cytosolic calcium to
a concentration that ranged from 500 to 900 nmol/l
(Figure 1A). The threshold concentration for elicitation
of a response to carbamylcholine was approximately 0.2 -
μmol/l. Responses to carbamylcholine were completely
blocked by a 10 min pretreatment with 10 μmol/l atro-
pine, and CHO cells not transfected with a muscarinic
receptor gene did not respond to carbamylcholine.
Addition of EDTA (5 mmol/l) to the external medium
caused a rapid decrease in [Ca2+]i, indicating that the
sustained elevation of [Ca2+]i following muscarinic re-
ceptor activation was dependent upon the entry of extra-
cellular calcium (Figure 1A).
The initial change in [Ca2+]i largely reflects calcium
release from the endoplasmic reticulum, while the sus-
tained plateau phase almost exclusively reflects calcium
entry from the extracellular medium [12,13]. Initial cal-
cium release from the ER is mediated by IP3 receptor
ionophores, while the plateau phase involves “capacitive”
calcium entry through Orai channels in the plasma
membrane. STIM1 proteins span the ER membrane and
possess a domain that senses calcium depletion. Calcium
depletion induces an interaction between STIM1 and
Orai, thereby activating the influx of extracellular cal-
cium [13,14]. This influx of extracellular calcium in re-
sponse to depletion of calcium in the endoplasmic
reticulum is referred to as store-operated calcium entry
(SOCE).
Honokiol blocked sustained calcium entry (i.e., SOCE)
at concentrations at which it did not affect initial calcium
release (i.e., calcium release from the ER (Figure 1B). For
example, 10 μmol/l honokiol completely inhibited SOCE
without significantly depressing the initial rise in [Ca2+]i.
At higher concentrations (20 and 30 μmol/l), honokiol
blocked both calcium responses.
When the cells were switched to a calcium-free BSS
3 min before imaging, the initial response to carbamyl-
choline remained largely intact at honokiol concentrations
up to 20 μmol/l (Figure 2A). These responses were not
maintained in the absence of extracellular calcium, and
cytosolic calcium concentrations declined to resting levels
within a few minutes. At 30 μmol/l, however, honokiol se-
verely depressed the response to carbamylcholine.
SOCE can also be observed following depletion of ER
calcium stores in the absence of extracellular calcium.
This depletion can be accomplished by stimulation of
muscarinic receptors (Figure 2) or by treating with
thapsigargin (1 μmol/l) to inhibit the sarco/endoplasmic
reticulum calcium-ATPases (SERCA) that transport cal-
cium into the ER against a large concentration gradient
(Figure 3). In response to this depletion, SOCE channels
open, although calcium is not available to enter the cell.
When [Ca2+]i levels return to a background level, influx
through SOCE channels can be visualized by adding
Figure 2 Influence of honokiol on cellular responses to
activation of M3 muscarinic receptors measured in the absence
of extracellular calcium. CHO cells expressing the human M3
receptor were loaded with fura-2 to monitor changes in cytosolic
calcium concentration. The cells were untreated or treated with the
indicated concentrations of honokiol for 10 min immediately before
measuring calcium content. Cells were switched to a calcium-free
BSS 3 min before imaging. Each line represents the average
response from 17-24 cells; each panel presents the results from a
separate experiment. Essentially similar results were obtained in
three other experiments. Carbamylcholine (10 μmol/l) was added at
the time indicated by the first arrow. Calcium was added to the
extracellular medium (final concentration = 2 mmol/l) at the time
indicated by the second arrow.
Wang et al. Journal of Biomedical Science 2013, 20:11 Page 3 of 8
http://www.jbiomedsci.com/content/20/1/11
calcium to the extracellular medium (2 mmol/l final con-
centration). These methods reveal a potent inhibitory ef-
fect of honokiol on SOCE. Again, inhibition of SOCE is
seen at honokiol concentrations that do not affect release
of calcium from the ER in response to carbamylcholine or
thapsigargin (Figures 2 & 3). Honokiol had a somewhat
inconsistent effect on thapsigargin-induced calcium re-
lease from the ER, depressing the rise in [Ca2+]i in some
experiments (e.g., Figure 3), but not in others. However, in
all cases, SOCE was more sensitive to honokiol inhibition
than ER-mediated calcium release.
In one series of experiments, the acute effects of honokiol
were determined by stimulating CHO-M3 cells with a
maximally effective concentration of carbamylcholine (10 -
μmol/l) followed by exposing the cells to honokiol during
the sustained phase of calcium entry (i.e., during SOCE).
Calcium entry was blocked by honokiol in a concentration-
dependent manner (Figure 4). The threshold for this inhi-
bition was between 1 and 3 μmol/l.
Honokiol had a biphasic effect on resting [Ca2+]i level.
Results gleaned from all of the experiments described in
this paper are summarized in Figure 5. At 1 and 3 μmol/l,
honokiol decreased [Ca2+]i by about 20%, but at 20 μmol/l
honokiol caused a large and variable increase in [Ca2+]i.
Honokiol cytotoxicity
CHO-M3 cell viability was revealed by the ability of CHO
cells to reduce MTS. Exposure of CHO cells to honokiol
for 24 h induced cytotoxicity in a concentration-dependent
manner (Figure 6). Cytotoxicity was not observed with
honokiol concentrations up to 32 μmol/l. Cytotoxicity
was 20% with 100 μmol/l honokiol and complete with 320 -
μmol/l honokiol. It is significant that a 10 min exposure
to honokiol inhibited SOCE at concentrations (e.g., 1 - 30 -
μmol/l) that did not cause cytotoxicity following a 24 h
exposure. In Figure 6, dose response relationships for
honokiol inhibition of SOCE are compared to the 24 h
cytotoxicity dose–response relationship. SOCE inhibition
by a 10 min exposure to honokiol was determined in
two ways: 1) depression of sustained calcium entry induced
by carbamylcholine (e.g., Figure 1B); and 2) inhibition of
calcium influx following thapsigargin depletion of ER cal-
cium (e.g., Figure 3). The EC50s for honokiol inhibition
of SOCE (10 min) were an order of magnitude lower
than the EC50 for honokiol cytotoxicity (24 h), and the
EC50s for the two measures of honokiol inhibition of
SOCE were similar.
Reversibility of honokiol effects on muscarinic signaling
The persistence of honokiol inhibition of SOCE is revealed
by the experiments depicted in Figure 7. After cells had
reached a plateau level of SOCE, honokiol was added
to the extracelluluar medium. High concentrations of
honokiol (10 and 30 μmol/l) inhibited calcium entry, while
3 μmol/l honokiol did not. The cells were washed 3 times
with fresh buffer to remove both the honokiol and
carbamylcholine. Within 10 min a stable baseline [Ca2+]i.
was obtained. After about 20 min, the cells were again
stimulated with 10 μmol/l carbamylcholine. The initial
response of control cells to the second application of
carbamylcholine was not affected, although [Ca2+]i. relaxed
to a plateau level that was 20% lower than the first plateau
level. This suggests a desensitization of a portion of the
response. In cells exposed to 3 and 10 μmol/l honokiol,
however, the initial response to the second application
of carbamylcholine was somewhat diminished (10-25%),
while the sustained plateau levels were severely depressed
(i.e., by 50-70%). This is consistent with a specific effect of
honokiol on SOCE that is only partially reversible. In con-
trast, cells exposed to 30 μmol/l honokiol failed to re-
sponse to the second application of carbamylcholine.
Influence of honokiol on ligand binding to muscarinic
receptors
The binding of [3H]MS to brain muscarinic receptors is
shown in Figure 8. Brain membranes were used as an
abundant source of muscarinic receptors. Approximately
40% of the neocortical receptors are of the M3 subtype.
Saturation binding curves were performed in the ab-
sence and presence of 10 μmol/l honokiol. Honokiol did
not affect the apparent concentration of receptors
(Bmax = 1.3 ± 0.2 and 1.2 ± 0.2 pmol/mg protein in the
Figure 3 Influence of honokiol on cytosolic calcium
concentrations in calcium-free BSS in response to thapsigargin-
induced depletion of calcium from the ER and to the
subsequent reintroduction of extracellular calcium. CHO-M3
cells were untreated or treated with various concentrations of
honokiol, as indicated, for 10 min before measuring calcium content.
The cells were switched to a calcium-free BSS 3 min before imaging.
Thapsigargin (1 μmol/l) was added at the time indicated by the first
arrow. Calcium was added to the extracellular medium (final
concentration = 2 mmol/l) at the time indicated by the second
arrow. Each line represents the average from four experiments, each
with 15-22 cells per measurement.
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absence and presence of honokiol, respectively) or the
affinity of [3H]MS for the receptors (0.40 ± 0.03 and
0.35 ± 0.5 nmol/l, respectively) (Figure 8A). Agonist
binding to muscarinic receptors is sensitive to multiple
aspects of receptor organization, including coupling to
G proteins. However, agonist binding, as revealed by the
ability of carbamylcholine to inhibit the binding of 0.3 -
nmol/l [3H]MS to the receptor was not affected by 10 -
μmol/l honokiol (Figure 8B).
Discussion
Muscarinic signaling in CHO cells
The influence of honokiol on muscarinic signaling was
investigated in CHO cells expressing the human M3
muscarinic receptor. In wild-type CHO cells, we cannot
detect acetylcholinesterase activity, muscarinic receptor
binding, or muscarinic signaling as reflected in either
calcium mobilization or alteration of cAMP synthesis in
response to carbamylcholine. However, CHO cells ex-
press components of both the phospholipase Cβ [15]
and adenylate cyclase [16] signaling pathways, and CHO
cells transfected with transgenes for the different mus-
carinic receptor subtypes respond to muscarinic agonists
in pharmacologically and physiologically appropriate
fashions: Activation of human M1, M3 or M5 receptors
expressed in CHO cells leads to the production of IP3,
release of calcium from the ER, activation of SOCE, and
modulation of the expression of genes under control of
Figure 5 Influence of honokiol on resting calcium
concentrations in CHO-M3 cells. This figure summarizes the
effects of a 10 min exposure to honokiol at the indicated
concentrations on the initial resting calcium concentration. Calcium
concentrations are expressed as fraction of the calcium
concentration in control cells not exposed to honokiol in the same
experiment. Significant differences in the calcium concentrations of
treated cells compared to control cells are indicated by the asterisks






























Figure 6 Cytotoxicity of honokiol and comparison to honokiol
inhibition of SOCE. The cytotoxicity of honokiol following a 24 h
exposure period is presented as fractional decrease in cells capable
of maintaining an intracellular reducing environment (open circles).
Fractional inhibition of SOCE by a 10 min exposure to honokiol was
determined in two ways: 1) depression of sustained calcium entry
(●) (e.g., Figure 1) and 2) inhibition of calcium influx following
thapsigargin depletion of ER calcium stores (▲) (e.g., Figure 3).
Figure 4 Acute effect of honokiol on SOCE. CHO-M3 cells were stimulated with 10 μmol/l carbamylcholine at 40 sec. Honokiol was added to
the extracellular medium at the time indicated by the arrow. Each line represents the average from 19-21 cells; three other experiments yielded
essentially similar results.
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the AP-1 or NFAT response elements [15] (AL Martin
et al., unpublished observations). Activation of human
M2 and M4 receptors expressed in CHO cells leads to
the inhibition of forskolin-stimulated cAMP formation
and alteration of the expression of genes under the control
of the cAMP response element (CRE) [15] (AL Martin
et al., unpublished observations).
M3 receptors activate Gαq transducer proteins that
stimulate phospholipase Cβ (PLCβ) [17]. PLCβ hydrolyzes
phosphatidylinositol 4.5-bisphosphate, releasing both dia-
cylglycerol and inositol trisphosphate (IP3). IP3 binds to
the IP3 receptor/ionophore on the endoplasmic reticulum
(ER) to release calcium into the cytosol. Sensors in STIM1
proteins that span ER membranes are sensitive to the de-
pletion of ER calcium. This leads to a close apposition
of ER and plasma membranes, allowing STIM1 proteins
to interact with Orai channel proteins in the plasma
membrane, thereby stimulating the entry of extracellular
calcium. This is called capacitive calcium entry or store-
operated calcium entry (SOCE) [11,13,18].
Honokiol disruption of muscarinic signaling
Calcium release from the ER through the IP3 receptor
ionophore was visualized as the initial release of calcium
in response to carbamylcholine. This release was not
affected by honokiol in either the presence or absence of
extracellular calcium (Figures 1 & 2). Honokiol had vari-
able effects on calcium release from the ER induced by
thapsigargin. In multiple instances, honokiol did not
affect thapsigargin-induced release at concentrations that
Arrows: 
1.  10 M carb 
2.  honokiol
3.  wash 
4. 10 M carb 
1 2 3 4
Figure 7 Reversibility of honokiol effects on calcium signaling. Carbamylcholine (10 μmol/l) was added at the point indicated by the first
arrow. Honokiol (3, 10 or 30 μmol/l, as indicated) was added at the time indicated by the second arrow. The cells were washed 3 times over a
2 min period with fresh media, beginning at the time indicated by the third arrow. The cells were again stimulated with carbamylcholine
(10 μmol/l) at the time indicated by the fourth arrow. The data is the average from 19-22 cells from a representative experiment performed 3
times with essentially similar results.
Figure 8 Influence of honokiol on ligand binding to muscarinic receptors in rat neocortical membranes. A: The binding of [3H]MS was
determined in the absence) open circles) and presence (closed circles) of 10 μmol/l honokiol. Lines are drawn according to nonlinear regression
to a model incorporating a single population of independent binding sites that revealed the following binding parameters in the absence and
presence of honokiol, respectively: Bmax = 1.3 ± 0.2 and 1.2 ± 0.2 pmol/mg; KD = 0.40 ± 0.03 and 0.35 ± 0.5 nmol/l; N = 3). B: Influence of honokiol
on agonist binding to neural muscarinic receptors revealed by the ability of carbamylcholine to inhibit the specific binding of 0.2 nmol/l [3H]MS.
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produced strong inhibition of SOCE. However, at higher
concentrations, an inhibition of both thapsigargin-
induced release and SOCE was observed. The precise
relationship between the thapsigargin-induced release,
ER calcium concentration, and SOCE gating requires add-
itional clarification.
SOCE was visualized by depleting calcium from the
ER by stimulating the muscarinic-IP3 receptor pathway
or by inhibiting SERCA pumps in the absence of extra-
cellular calcium. When [Ca2+]i returned to its baseline
level (3-5 min), calcium was added to the extracellular
medium (final concentration = 2 mmol/l). Calcium im-
mediately entered the cell via the SOCE channels that
had opened in response to depletion of ER calcium. In
both paradigms, honokiol displayed a strong inhibition
of extracellular calcium entry through SOCE channels.
Honokiol’s effect on SOCE was selective insofar as
honokiol inhibited SOCE at lower concentrations than
it affected ER calcium release induced by either IP3 re-
ceptor activation or thapsigargin inhibition of SERCA.
Honokiol’s effect was rapid and partially reversible (at
concentrations below 30 μmol/l), and was observed at
concentrations and under conditions in which honokiol
was not cytotoxic and did not interfere with ligand bind-
ing to the muscarinic receptor. Previous work has
documented honokiol inhibition of muscarinic receptor-
and depolarization-mediated contraction of isolated por-
cine trachea, guinea pig ileum and rat uterus, apparently
by blocking the influx of extracellular calcium [8-10].
The present work suggests that an inhibition of SOCE
is the mechanism underlying these effects on autonomic
signaling.
The threshold for honokiol inhibitory effects in vitro
was ≈ 3 μM. This is consistent with the concentration de-
pendence of in vitro antiinflammatory, antithrombosis, sig-
naling and antioxidant effects of honokiol. For example,
Alexeev et al. [19] noted magnonol and honokiol effects on
GABAergic transmission in the 1-30 μM range, Tian et al.
used 150 μM honkiol to enhance cell death of cultured
cancer cells [20], Nagalingam et al. found that honokiol
concentrations of 5 μM honokiol were required to inhibit
the clonogenicity of cultured breast cancer cells by activa-
tion of AMP-activated protein kinase [21], and Fukuyama
et al., demonstrated a neurtorphic acivity (neurtie out-
growth) of 0.1 – 10 μM honokiol on cultured rat cortical
neurons [22]. Moreover, Lu et al. used 1 -100 μM honokiol
to inhibit responses of uteri to cholinergic agonists [10]
and Ko et al used 0.1 -100 μM honokiol to inhibited cho-
linergic responses of tracheal muscle [9].
In earlier work we demonstrated that oxidative stress
(e.g., by exposure to metal oxide nanoparticles) also has
a selective inhibitory effect on SOCE [15]. Honokiol,
however, has antioxidant properties and is cytoprotective
in the face of multiple insults, including oxidative stress.
This raises the possibility that honokiol actions reflect
a direct interaction with the ion channel (Orai) itself, ra-
ther than an indirect effect on the redox state of the cell.
This would be consistent with honokiol’s antioxidant ac-
tivity, lack of cytotoxicity, and rapid and partially revers-
ible inhibition of SOCE. Another possibility that remains
to be evaluated is whether honokiol disrupts Orai –
Stim1 interactions. It is interesting that honokiol, unlike
most pharmacologically exploited ion channel blockers,
is not a hydrophobic amine.
The effect of honokiol on resting [Ca2+]i. was biphasic.
The decrease in [Ca2+]i. at honokiol concentrations
below 10 μmol/l might reflect the role of Orai channels
as one of the transport mechanisms that determine cel-
lular calcium concentration [23]. It is also possible that
honokiol alters the resting calcium content aof the endo-
plasmic reticulum, which might reflect changes in active
sequestration mechanisms (SERCA) or ER channel con-
ductances. Increases in resting [Ca2+]i. are associated
with incipient cytotoxicity. Honokiol recently was re-
ported to promote calcium release associated with mito-
chondrial dysfunction in human chondrosarcoma cells
[24]. However, even at high and ultimately cytotoxic
concentrations of honokiol, virtually all of the cells
remained capable of maintaining [Ca2+]i at constant
levels over the time course of these acute experiments.
Conclusions
Honokiol had a potent inhibitory effect on store operated
calcium entry (SOCE) stimulated by activation of the M3
muscarinic receptors. This effect was specific, rapid and
partially reversible, and was seen at concentrations not
associated with cytotoxicity, inhibition of IP3 receptor-
mediated release, or disruption of M3 receptor binding. It
is likely that inhibition of SOCE accounts for honokiol
disruption of parasympathetic motor functions, and may
contribute to certain of its beneficial pharmacological
properties.
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